Max Healthcare Institute Ltd - Stock Valuation and Financial Performance

BSE: 543220 | NSE: MAXHEALTH | Hospital & Healthcare Services | Mid Cap

Max Healthcare Inst Share Price

869.45 4.55 0.53%
as on 12-Apr'24 16:59

DeciZen - make an informed investing decision on Max Healthcare Inst

Overall Rating
Bole Toh

2. Valuation

Overvalued

3. Price Trend

Max Healthcare Institute stock performance -

mw4me loader
P/E Ratio (CD):
79.94
Market Cap:
84,502.9 Cr.
52-wk low:
435.1
52-wk high:
909

Is Max Healthcare Institute Ltd an attractive stock to invest in?

1. Is Max Healthcare Institute Ltd a good quality company?

Data is not available for this company.

2. Is Max Healthcare Institute Ltd undervalued or overvalued?

The key valuation ratios of Max Healthcare Institute Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Max Healthcare Institute Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Max Healthcare Institute Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Max Healthcare Inst:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -1.9%0.4%1.5%3.5%1.9%3.5%4.4%2.8%10.1%15.5%-
Value Creation
Index
-1.2-1.0-0.9-0.7-0.8-0.7-0.6-0.8-0.10.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 9441,1341,4341,6081,7291,6911,0592,5083,9374,5635,198
Sales YoY Gr.-20%26.5%12.1%7.5%-2.2%-37.4%136.8%57%15.9%-
Adj EPS -1.5-0.8-0.5-0-0.6-01.10.16.311.410.9
YoY Gr.-NANANANANANA-87.3%4421.4%79.3%-
BVPS (₹) 11.31721.522.221.717.947.558.164.675.983.7
Adj Net
Profit
-63-38-24.4-1.9-31-259.213.76131,1021,057
Cash Flow from Ops. 73.263.872315682.28977.11187411,209-
Debt/CF from Ops. 6.66.61.15.611.911.311.17.810.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 19.1%21.4%62.7%15.9%
Adj EPS NANA117.7%79.3%
BVPS23.5%28.4%16.9%17.5%
Share Price - - 58.2% 84.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-11.5-5.5-2.5-0.2-2.6-0.23.40.310.316.113.6
Op. Profit
Mgn %
3.46.77.28.86.68.78.415.323.926.927.9
Net Profit
Mgn %
-6.7-3.4-1.7-0.1-1.60.11.21.515.624.220.3
Debt to
Equity
0.90.50.70.70.810.30.20.10.1-
Working Cap
Days
016116217918821732015413211575
Cash Conv.
Cycle
03-24-21-21-22-11-15-14-2137

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 13.60%

Sales growth is growing at healthy rate in last 3 years 62.72%

Net Profit is growing at healthy rate in last 3 years 117.70%

Sales growth is good in last 4 quarters at 21.65%

No data to display

Latest Financials - Max Healthcare Institute Ltd.

Standalone Consolidated
TTM EPS (₹) 5.9 10.9
TTM Sales (₹ Cr.) 2,239 5,198
BVPS (₹.) 76.3 83.7
Reserves (₹ Cr.) 6,441 7,164
P/BV 11.40 10.39
PE 147.77 79.94
From the Market
52 Week Low / High (₹) 435.10 / 909.00
All Time Low / High (₹) 101.65 / 909.00
Market Cap (₹ Cr.) 84,503
Equity (₹ Cr.) 971.9
Face Value (₹) 10
Industry PE 87.4

Management X-Ray of Max Healthcare Inst:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.0042.6951.1551.150.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Max Healthcare Inst

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales9441,1341,4341,6081,7291,6911,0592,5083,9374,563
Operating Expenses 9151,0581,3311,4681,6161,5469702,1242,9983,335
Manufacturing Costs274327611461651583597221,0581,264
Material Costs328346399423426364217594923922
Employee Cost 189232305353423441230589760809
Other Costs 124154566545603582164219257339
Operating Profit 3075104140113146893849381,227
Operating Profit Margin (%) 3.2%6.6%7.2%8.7%6.5%8.6%8.4%15.3%23.8%26.9%
Other Income 23273642556753135132152
Interest 626168100991018317910184
Depreciation 557891969410346174221232
Exceptional Items 0000000-234-90
Profit Before Tax -64-37-19-12-26813-697391,064
Tax 004-1129046134-40
Profit After Tax -65-37-23-1-29013-1156051,104
PAT Margin (%) -6.8%-3.3%-1.6%-0.1%-1.7%0.0%1.2%-4.6%15.4%24.2%
Adjusted EPS (₹)-1.5-0.8-0.40.3-0.4-0.11.1-1.46.211.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%9%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 5498311,1451,1921,1679632,5535,6126,2607,368
Share Capital 493489533537537537537966970971
Reserves 563436126556304262,0164,6465,2916,397
Minority Interest00-17-73-13300000
Debt455378769859953964834897704542
Long Term Debt346332649772849890106843629497
Short Term Debt109461218710474727547546
Trade Payables154155217214267292180436444543
Others Liabilities 122889309541,0511,1364071,5991,7811,648
Total Liabilities 1,2801,4533,0453,1463,3043,3553,9748,5439,18910,102

Fixed Assets

Gross Block1,0111,0502,3572,4232,4642,5571,2527,0997,7607,958
Accumulated Depreciation23631184178237365401563742920
Net Fixed Assets7757402,2732,2442,2272,1928516,5367,0187,039
CWIP 1518124638872827151252
Investments 014300012,182111
Inventories15192323282627546176
Trade Receivables16417320923525836396366385336
Cash Equivalents 1627132390121206534991,468
Others Assets2943325165756636746719071,074930
Total Assets 1,2801,4533,0453,1463,3043,3553,9748,5439,18910,102

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 73647231568289771187411,209
PBT -65-37-19-12-26813-697391,064
Adjustment 103126145194162157109505241226
Changes in Working Capital 39-92729-25-48-39-376-13181
Tax Paid -5-16327-35-23-28-658-109-161
Cash Flow From Investing Activity -31-194-1,340-104-100-17-2,641-73-764-1,187
Capex -51-71-1,603-115-66-116-90-117-548-332
Net Investments -5-3790-6-7376-2,1360-171-1,076
Others 25257263173923-41544-44220
Cash Flow From Financing Activity -52145603-4812-742,353191-294-289
Net Proceeds from Shares 424092830001,8581,17941
Net Proceeds from Borrowing 033841058922-135-95-213-133
Interest Paid -58-60-65-95-94-96-78-155-72-55
Dividend Paid 0000000000
Others -36-2070-58170708-737-13-102
Net Cash Flow -916-144-6-2-210236-317-266
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-13.37-5.64-2.29-0.12-2.44-0.020.73-2.810.1916.19
ROCE (%)-0.22.113.054.343.465.333.572.2212.3815.32
Asset Turnover Ratio0.740.830.640.520.540.510.290.40.440.47
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A5.92N/A1.221.1
Working Capital Days
Receivable Days64544950526779343529
Inventory Days6555569656
Payable Days171163170186206279396189174195

Max Healthcare Institute Ltd Stock News

Max Healthcare Institute Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Max Healthcare Inst on 12-Apr-2024 16:59 is ₹869.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2024 16:59 the market cap of Max Healthcare Inst stood at ₹84,502.9.
The latest P/E ratio of Max Healthcare Inst as of 12-Apr-2024 16:59 is 147.8.
The latest P/B ratio of Max Healthcare Inst as of 12-Apr-2024 16:59 is 11.40.
The 52-week high of Max Healthcare Inst is ₹909.0 and the 52-week low is ₹435.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Max Healthcare Inst is ₹2,239 ( Cr.) .

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited is the second largest healthcare chain in India by revenue with a network of various Healthcare Facilities, including BLK Super Speciality Hospital and Nanavati Super Speciality Hospital (post de-merger of Radiant’s healthcare business into the company). Its network includes four Partner Healthcare Facilities, to whom it provide healthcare services in key specialities pursuant to prevailing agreements. It has major concentration in north India with many hospitals and medical centres located in Delhi NCR and the others in the cities of Mumbai, Mohali, Bathinda and Dehradun.

The company commenced operations in the year 2000 with its first hospital, Max Medcentre in Panchsheel Park, and expanded its operations by opening various multi-speciality hospitals and entering into arrangements with societies and trusts. It provides healthcare services across secondary and tertiary care specialities with key focus on centres of excellence i.e. oncology, neurosciences, cardiac sciences, orthopaedics, renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (MAMBS).

In addition to the core hospital business, the company has two SBUs, namely, Max@Home and MaxLab. Max@Home is a platform that provides health and wellness services at home and MaxLab offers pathology services to patients outside of its hospitals through a variety of channels including third party hospital laboratory management.

Max Healthcare is promoted and led by Abhay Soi as its Chairman and Managing director and co- promoted by KKR, the iconic Global Private equity fund.  The present amalgamated company was formed subsequent to the acquisition of 49.7% stake in erstwhile Max Healthcare Institute Limited by Radiant Life Care Pvt. Ltd. (Radiant) and the amalgamation of Max Healthcare with Radiant thereafter. The amalgamated entity assumed the name Max Healthcare Institute limited. Prior to the amalgamation, Radiant was led and promoted by Abhay Soi.

Business area of the company

The company offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda. It provides services in the areas of cardiology, orthopedics and joint replacement, cancer, neurosciences, pediatrics, obstetrics and gynecology, aesthetics and reconstructive plastic surgery, internal medicine, eye and dental care, endocrinology, diabetes, obesity, ENT, metal health and behavioral sciences, physiotherapy and rehabilitation, and nuclear medicine, as well as minimal access, metabolic, and bariatric surgery.

Awards & recognitions

2019-2020

  • Max Super Speciality Hospital, Saket was awarded the ‘Patient Safety Award’ for ‘Project Nursing Excellence’ by the Federation of Indian Chambers of Commerce & Industry.
  • Max Super Speciality Hospital, Patparganj was awarded Diamond Award for Stroke Ready Centre by the World Stroke Organisation.
  • Max Smart Super Speciality Hospital, Saket won the Nursing Excellence Award at AHPI Healthcare Excellence Awards 2020.
  • BLK Super Speciality Hospital, Pusa Road won the Best Hospital - Neurology (National) Best Hospital - Gastroenterology & Hepatology (North) Best Hospital - Orthopaedic (North), Best Multi-Speciality Hospital (North) and Best Hospital-Cardiology (North) at ET Healthworld Awards 2020.
  • FICCI Excellence Awards for ‘Operational Excellence’ was awarded to the mpany by the Federation of Indian Chambers of Commerce and Industry.
  • Max Super Speciality Hospital, Vaishali won the award for Quality Beyond Accreditation at AHPI Healthcare Excellence Awards 2020.
  • BLK Super Speciality Hospital, Pusa Road won the Award for Quality Beyond Accreditation at AHPI Healthcare Excellence Awards 2020.
  • Max Super Speciality Hospital, Saket won the Best Hi-Tech Hospital (National) at ET Healthworld Awards 2020.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.